N,1,N1,N4-TRIS(1H-BENZIMIDAZOL-2-YLMETHYL)-N,4-((8S)-5,6,7,8-TETRAHYDRO-8-QUINOLINYL)-1,4-BUTANEDIAMINE
UNII 2PZ3KQ9B5S
Substance Identification & Data
This profile provides standardized clinical and technical data for N,1,n1,n4-tris(1h-benzimidazol-2-ylmethyl)-n,4-((8s)-5,6,7,8-tetrahydro-8-quinolinyl)-1,4-butanediamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2PZ3KQ9B5S.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2785361-91-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C37H39N9 MAZNWWJEJJCUJX-XIFFEERXSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N,1,n1,n4-tris(1h-benzimidazol-2-ylmethyl)-n,4-((8s)-5,6,7,8-tetrahydro-8-quinolinyl)-1,4-butanediamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.